BioPharma Pharma Research

Biopharmaceuticals: Faster to Market

To combat these challenges, biopharmaceuticals that are produced with the help of living organisms are playing an increasingly important role. However, the...

 April 21, 2022 | Opinion

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn

Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia ...

 April 14, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

 April 14, 2022 | News

Cambrex Completes Large-Scale US API Expansion

The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex's fl...

 April 13, 2022 | News

Jackson ImmunoResearch announces new range of detection reagents for R&D and diagnostic markets

Jackson ImmunoResearch, manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new range of detection reagents th...

 April 13, 2022 | News

Debiopharm announces oncology research advancements

Debiopharm, (www.debiopharm.com/debiopharm-international/) an oncology and infectious disease focused biopharmaceutical company based in Switzerland, ...

 April 12, 2022 | News

Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative

Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by inves...

 April 12, 2022 | News

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...

 April 07, 2022 | News

CR Pharma intends to make strategic equity investment for Everest's mRNA technology platform

Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancemen...

 April 07, 2022 | News

Singlera Genomics announces research collaboration with Astellas Pharma

Singlera Genomics Inc. today announced a research collaboration with Astellas Pharma Inc. to develop methylation-based tools to better understand biologica...

 April 06, 2022 | News

Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in China

On April 3, 2022, Ascletis' distributor, Zhejiang Int'l Medicine Co., Ltd. ("Zhejiang Int'l"), completed the first sale of Ascletis' ritonavir tablets...

 April 05, 2022 | News

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in Mantle Cell Lymphoma in China

Carteyva® is an anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product independently developed by JW Therapeutics. T...

 April 04, 2022 | News

Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06

The Phase I clinical trial, a randomized, double-blind and placebo-controlled study, is to evaluate the safety, pharmacokinetics and pharmacodynamics of si...

 April 01, 2022 | News

Aivia software update from Leica Microsystems offers improved AI image analysis capabilities

Leica Microsystems, a leader in microscopy and scientific instrumentation, has released Aivia 10.5, the latest version of its AI based image visualization,...

 March 31, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close